Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ROZETELA: Co-administration of Rosuvastatin/Ezetimibe and Telmisartan/Amlodipine
NCT04158076Phase 3Completed
- Sponsor
- Addpharma, Inc.
- Start
- Jan 2020
- Primary completion
- Jan 2021
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of rosuvastatin, ezetimibe, telmisartan, amlodipine in hypercholesterolemia, essential hypertension, sponsored by Addpharma, Inc.. Started Jan 2020; status: completed.
02
Drugs
rosuvastatinezetimibetelmisartanamlodipine
03
Conditions
hypercholesterolemiaessential hypertension
Beyond the preview
Go deeper on NCT04158076.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04158076.